膜曝氣生物膜反應器市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、處理能力、地區和競爭對手分類，2021-2031年

全球膜曝氣生物膜反應器市場預計將從 2025 年的 18.6 億美元成長到 2031 年的 25.9 億美元，複合年成長率為 5.67%。

這種生物污水處理技術利用滲透性膜直接向生物膜供氧，從而在單一反應器內實現硝化和反硝化同步進行。透過採用無氣泡曝氣，其氧氣傳輸效率遠高於傳統的擴散技術。該領域的發展主要受日益嚴格的營養物去除法規以及老舊設施維修的需求所驅動，旨在提高處理能力的同時，又不增加面積。此外，業界為實現能源中和所做的努力也加速了該技術的應用，並且這些系統透過改進曝氣機制顯著降低了營運成本。

然而，專用膜組件所需的大量初始投資，以及長期生物膜控制和污垢管理方面的技術挑戰，阻礙了市場的廣泛擴張。這些維護要求對於缺乏先進技術能力的小規模市政當局來說可能構成障礙。儘管有這些挑戰，但其高運作效率仍是公共產業事業的一大優勢。根據國際水協會 (IWA) 2024 年的報告，與傳統的活性污泥法相比，薄膜生物反應器 (MABR) 技術可將曝氣能耗降低高達 50%，並已成為永續城市水資源管理策略的關鍵組成部分。

市場促進因素

更新和維修老舊基礎設施的需求是推動成長的重要因素。主要原因是膜生物反應器（MABR）技術能夠在現有處理池內提升處理能力。這種「即插即用」的特性對於那些缺乏空間和資金開展新土木工程項目，同時又面臨嚴格營養物排放法規的市政當局至關重要。透過將膜組件直接懸掛在現有的厭氧區，操作人員可以同時維持硝化生物膜和懸浮污泥，從而顯著提高處理性能。例如，正如WaterProjectsOnline在2024年12月報導的那樣，塞文特倫特水務公司（Severn Trent Water）的蒙克穆爾（Monkmoor）污水處理廠維修使用了48個OxyMem MABR組件，實現了每日243公斤氮當量的氨去除率，超過設計了162公斤的目標。

同時，快速的都市化和不斷擴張的工業活動正在推動相關技術的應用，高負荷的製造工廠需要高效的複雜廢水處理方案。食品加工和造紙等行業擴大使用此類反應器來處理高濃度污水，同時滿足環保標準。 Fluence 公司在 2024 年 3 月訂單了義大利一家再生紙廠價值 230 萬美元的訂單，為其建造一座日處理量 7500 立方米的 MABR 裝置，這充分體現了市場對 MABR 的強勁需求。這種市場動能也體現在區域採購績效。 Fluence 公司在 2024 年 3 月報告稱，其在北美地區的前兩個月訂單達到 330 萬美元，超過了去年在該地區的總銷售額。

市場挑戰

專用膜組件所需的大量前期投資是膜曝氣生物膜反應器（MABR）技術廣泛應用的主要障礙。雖然該系統能夠長期節省營運成本，但這些先進曝氣設備的前期投資遠高於傳統曝氣器。生物膜厚度控制和污染預防的技術複雜性進一步加劇了這項財務挑戰。這些工作需要熟練的人員和嚴格的維護程序，而小規模公共工程項目往往缺乏這些條件。因此，儘管預期未來效率將即時提升，但出於規避風險的考慮，市政領導常常以購買和培訓成本為由，推遲升級到這種更有效率的系統。

全球水務產業普遍面臨的財務壓力進一步加劇了這種不情願。在預算限制下，支持高階基礎建設支出變得困難重重。國際水協會（IWA）指出，2024年，在受調查的全球城市中，三分之一城市的污水處理相關環境費用將佔總水費的50%以上。這一數字凸顯了供水事業預算面臨的巨大壓力，直接限制了他們承擔部署先進膜生物反應器（MABR）基礎設施相關高昂成本的能力。這種財務限制實際上阻礙了市場成長，因為只有資金雄厚的供水事業才能參與其中。

市場趨勢

模組化和貨櫃式膜生物反應器（MABR）裝置的興起正在改變市場格局，為分散式應用提供靈活的即插即用處理方案。與需要大規模土木工程的集中式系統不同，這些預包裝解決方案使市政當局和私人開發商能夠在偏遠或空間受限的地區快速建立生物處理能力。這種供應方式顯著縮短了安裝時間和初始建造成本，即使在資金有限的小規模社區和商業計劃中，也能實現高效的營養物去除。該領域的商業性成功持續成長。根據Fluence公司2024年4月發布的季度活動報告，其智慧產品解決方案部門（包括模組化MABR產品）第一季的銷售額較去年同期成長了50%。

同時，隨著全球水務產業聚焦淨零排放目標，市場正穩步向能源中和、低碳營運模式轉型。公共事業公司擴大選擇膜生物反應器（MABR）技術，不僅是為了滿足監管要求，更是為了將其視為一項戰略資產，以將污水處理與高電力消耗及其產生的碳足跡脫鉤。這些系統採用被動曝氣膜，無需高能耗鼓風機，顯著降低了範圍2排放，並透過其長期永續性優勢證明了高額投資的合理性。大型公共產業的支出趨勢也反映了這個策略方向。根據《水務業雜誌》2024年3月報道，塞文特倫特水務公司投資620萬英鎊升級其蒙克穆爾MABR設施，旨在使其先進處理能力與其更廣泛的碳減排目標保持一致。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球膜曝氣生物膜反應器市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（模組化、貨櫃式、混凝土攪拌站）
  • 透過申請（適用於地方政府、產業）
  • 依類別分類的處理能力（1立方公尺/天至50立方公尺/天，50立方公尺/天至150立方公尺/天，150立方公尺/天至500立方公尺/天，超過500立方公尺/天）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美膜曝氣生物膜反應器市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲膜曝氣生物膜反應器市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區膜曝氣生物膜反應器市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲膜曝氣生物膜反應器市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美膜曝氣生物膜反應器市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球膜曝氣生物膜反應器市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Xylem Inc.
• Pentair plc
• Aqua-Aerobic Systems, Inc.
• EnviroChemie GmbH
• BASF SE
• Emerson Electric Co.
• ITT Inc.
• Tetra Tech, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Membrane Aerated Biofilm Reactor Market is projected to expand from USD 1.86 Billion in 2025 to USD 2.59 Billion by 2031, reflecting a compound annual growth rate of 5.67%. This biological wastewater treatment method leverages gas-permeable membranes to supply oxygen directly to a biofilm, facilitating simultaneous nitrification and denitrification within a single reactor. By utilizing bubble-free aeration, the process achieves superior oxygen transfer efficiency relative to traditional diffusion techniques. Growth in this sector is primarily fueled by stricter nutrient removal mandates and the need to retrofit aging facilities to boost capacity without enlarging their physical footprint. Additionally, the industry's push toward energy neutrality fosters adoption, as these systems provide significant operational cost savings through enhanced aeration mechanics.

However, broad market expansion is hindered by the substantial initial capital investment needed for specialized membrane modules and the technical difficulties involved in long-term biofilm control and fouling management. These maintenance requirements can be a deterrent for smaller municipalities lacking extensive technical capabilities. Despite these obstacles, operational efficiency remains a compelling advantage for utility operators. According to the International Water Association's 2024 report, MABR technology can lower aeration energy usage by as much as 50% compared to conventional activated sludge systems, establishing it as a vital element in sustainable urban water management strategies.

Market Driver

The necessity to upgrade and retrofit aging infrastructure acts as a primary catalyst for growth, largely because MABR technology enables utilities to increase treatment capacity within existing basin boundaries. This "drop-in" functionality is crucial for municipalities encountering rigorous nutrient discharge regulations yet lacking the space or funds for new civil construction. By suspending membrane modules directly into existing anoxic zones, operators can support both nitrifying biofilms and suspended sludge, leading to marked performance improvements. For example, WaterProjectsOnline noted in December 2024 that the retrofit of Severn Trent Water's Monkmoor Sewage Treatment Works, using 48 OxyMem MABR modules, achieved an ammonia removal rate of 243 kilograms of nitrogen daily, exceeding the design target of 162 kilograms.

Concurrently, rapid urbanization and expanding industrial activities are driving adoption, as high-load manufacturing plants require effective solutions for complex effluents. Industries such as food processing and paper manufacturing are increasingly utilizing these reactors to manage high-strength wastewater while meeting environmental standards. Fluence Corporation highlighted this demand in March 2024 by securing a $2.3 million contract for a 7,500 cubic meter per day MABR plant at an Italian recycled paper mill. The market momentum generated by these factors is reflected in regional procurement figures; Fluence Corporation reported in March 2024 that it secured $3.3 million in North American municipal bookings during the first two months of the year, surpassing the region's total sales for the previous year.

Market Challenge

The substantial initial capital outlay required for specialized membrane modules poses a significant obstacle to the widespread implementation of Membrane Aerated Biofilm Reactor technology. Although the system offers long-term operational cost reductions, the upfront investment for these advanced aeration units is considerably higher than that for traditional diffusers. This financial challenge is exacerbated by the technical complexities involved in managing biofilm thickness and mitigating fouling, tasks that demand skilled staff and strict maintenance routines often missing in smaller utility operations. As a result, risk-averse municipal leaders frequently postpone upgrading to this efficient architecture, considering the immediate acquisition and training expenses to be prohibitive despite the promise of future efficiency enhancements.

This reluctance is further entrenched by the general financial stress impacting the global water sector, where constrained budgets struggle to support premium infrastructure spending. According to the International Water Association, in 2024, environmental fees related to wastewater treatment constituted more than 50% of the total water bill in one-third of cities surveyed globally. This figure highlights the severe pressure on utility budgets, which directly restricts the fiscal ability of operators to bear the high costs linked to deploying advanced MABR infrastructure. Such financial limitations effectively impede market growth by limiting access to only the most well-funded utility providers.

Market Trends

The rise of modular and containerized MABR units is transforming the market by offering flexible, plug-and-play treatment options for decentralized uses. Unlike centralized systems that demand extensive civil engineering, these pre-packaged solutions enable municipalities and private developers to quickly establish biological treatment capacity in remote or space-limited areas. This delivery approach drastically cuts installation times and upfront construction expenses, making high-performance nutrient removal attainable for smaller communities and commercial projects lacking the funds for custom facilities. The commercial success of this sector is growing; Fluence Corporation's April 2024 'Quarterly Activities Report' noted that its Smart Product Solutions division, which houses its modular MABR line, saw a 50% revenue jump in the first quarter compared to the same period the prior year.

At the same time, the market is moving decisively toward energy-neutral and low-carbon operations, motivated by the global water sector's dedication to net-zero emission goals. Utilities are increasingly selecting MABR technology not merely for regulatory compliance, but as a strategic asset to disconnect wastewater treatment from high electricity usage and the resulting carbon footprints. By employing passive aeration membranes that remove the need for energy-consuming blowers, these systems substantially reduce Scope 2 emissions, warranting premium investments through long-term sustainability benefits. This strategic direction is clear in major utility spending; as reported by Water Industry Journal in March 2024, Severn Trent Water allocated £6.2 million for the Monkmoor MABR upgrade specifically to align the plant's enhanced treatment capacity with the company's wider carbon reduction objectives.

Key Market Players

• Xylem Inc.
• Pentair plc
• Aqua-Aerobic Systems, Inc.
• EnviroChemie GmbH
• BASF SE
• Emerson Electric Co.
• ITT Inc.
• Tetra Tech, Inc.

Report Scope

In this report, the Global Membrane Aerated Biofilm Reactor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Membrane Aerated Biofilm Reactor Market, By Type

• Modules
• Containerized
• Concrete Plants

Membrane Aerated Biofilm Reactor Market, By Application

• Municipal
• Industrial

Membrane Aerated Biofilm Reactor Market, By Treatment Capacity

• 1 m3/d - 50 m3/d
• 50 m3/d - 150 m3/d
• 150 m3/d - 500 m3/d
• Above 500 m3/d

Membrane Aerated Biofilm Reactor Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Aerated Biofilm Reactor Market.

Available Customizations:

Global Membrane Aerated Biofilm Reactor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Membrane Aerated Biofilm Reactor Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Modules, Containerized, Concrete Plants)
  • 5.2.2. By Application (Municipal, Industrial)
  • 5.2.3. By Treatment Capacity (1 m3/d - 50 m3/d, 50 m3/d - 150 m3/d, 150 m3/d - 500 m3/d, Above 500 m3/d)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Membrane Aerated Biofilm Reactor Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Treatment Capacity
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Treatment Capacity
  • 6.3.2. Canada Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Treatment Capacity
  • 6.3.3. Mexico Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Treatment Capacity

7. Europe Membrane Aerated Biofilm Reactor Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Treatment Capacity
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Treatment Capacity
  • 7.3.2. France Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Treatment Capacity
  • 7.3.3. United Kingdom Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Treatment Capacity
  • 7.3.4. Italy Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Treatment Capacity
  • 7.3.5. Spain Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Treatment Capacity

8. Asia Pacific Membrane Aerated Biofilm Reactor Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Treatment Capacity
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Treatment Capacity
  • 8.3.2. India Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Treatment Capacity
  • 8.3.3. Japan Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Treatment Capacity
  • 8.3.4. South Korea Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Treatment Capacity
  • 8.3.5. Australia Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Treatment Capacity

9. Middle East & Africa Membrane Aerated Biofilm Reactor Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Treatment Capacity
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Treatment Capacity
  • 9.3.2. UAE Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Treatment Capacity
  • 9.3.3. South Africa Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Treatment Capacity

10. South America Membrane Aerated Biofilm Reactor Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Treatment Capacity
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Treatment Capacity
  • 10.3.2. Colombia Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Treatment Capacity
  • 10.3.3. Argentina Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Treatment Capacity

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Membrane Aerated Biofilm Reactor Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Xylem Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pentair plc
• 15.3. Aqua-Aerobic Systems, Inc.
• 15.4. EnviroChemie GmbH
• 15.5. BASF SE
• 15.6. Emerson Electric Co.
• 15.7. ITT Inc.
• 15.8. Tetra Tech, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer